trending Market Intelligence /marketintelligence/en/news-insights/trending/hviya3qq_sy1OPkGGWGAfQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Sun Pharma recalls children's allergy drug from US, Puerto Rico markets

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Sun Pharma recalls children's allergy drug from US, Puerto Rico markets

Sun Pharmaceutical Industries Ltd.'s U.S. arm is recalling 13,200 bottles of children's cetirizine hydrochloride chewable tablets from the U.S. and Puerto Rico markets, according to an enforcement report by the U.S. FDA.

The ongoing class III recall by Sun Pharmaceutical Industries Inc. is for the 5 mg tablets, made at the company's Halol plant in Gujarat, India, because of failed tablet/capsule specifications.

The tablets are used for preventing or treating certain symptoms of hay fever and other upper respiratory allergies.